C
Centerline Biomedical
A Cleveland clinic spin-off, is developing an innovative system
About Centerline Biomedical
Centerline Biomedical, a spin-off from the Cleveland Clinic, specializes in advanced surgical navigation technology. The company's flagship product, the Intra Operative Positioning System (IOPS), is a 3D GPS-like system designed to enhance surgical precision, simplify complex procedures, and reduce radiation exposure for both patients and healthcare professionals. Operating primarily in the healthcare sector, Centerline Biomedical serves hospitals, surgical centers, and medical professionals who perform endovascular procedures. The business model revolves around the sale and licensing of its proprietary technology, along with providing ongoing support and training services. Revenue is generated through direct sales, licensing agreements, and service contracts. Centerline Biomedical's market includes healthcare institutions looking to improve surgical outcomes and patient safety through cutting-edge technology.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Warrensville Heights, United States
- Employees
- 35
- Open positions
- 1
- Dealroom signal
- 29.3/100
- Industry
- Enterprise Software
- Sector
- Other B2B Software, Biotechnology, Spinout, DT and LS
- Technology
- 3D Technology, Deep Tech
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Jun 2022 | $33M | $132M | G2 Venture Partners · JumpStart Ventures · GE Healthcare · RIK Enterprises | ↗ |
| EARLY VC✓Equity / VC | Mar 2020 | $10M | $40M | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Centerline Biomedical is 2.1K monthly website visits, up 31.3% over the last three months. Centerline Biomedical's team declined 12.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
MedTech Innovator
National Heart, Lung, and Blood Institute
Series A6 investors entered at this stage
Cleveland Clinic
G2 Venture Partners
JumpStart Ventures
GE Healthcare- RERIK Enterprises
JobsOhio
Other known investors5 additional known investors
- UJUniversity of Medicine and Dentistry of New Jersey
Great Lakes Innovation and Development Enterprise
Innovation Fund Northeast Ohio
JobsOhio Ventures
Small Business Innovation Research
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Centerline Biomedical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Centerline Biomedical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.